Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

Delayed Quote. Delayed  - 08/26 10:00:13 pm
42.98 USD   +0.33%
12:43a ABBOTT LABORATO : Whiplashed investors stay skittish about St. Jude
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
08/26 MUDDY WATERS SA : Cnbc
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies 
Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Historically, the company has been releasing figures that are above expectations.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
  • With an enterprise value anticipated at 3.16 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart
Subsector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
ABBOTT LABORATORIES-4.61%63 460
JOHNSON & JOHNSON15.43%324 776
ROCHE HOLDING LTD.-11.47%217 694
NOVARTIS AG-9.62%213 882
PFIZER INC.7.71%211 206
MERCK & CO., INC.17.99%173 462
GLAXOSMITHKLINE PLC21.19%106 869
SANOFI-12.76%100 405
BRISTOL-MYERS SQUIBB CO-14.58%97 896
ALLERGAN PLC-24.38%96 323
NOVO NORDISK A/S-21.38%95 801
Autres valeurs du secteur
Company
Engages in the discovery, development, manufacture and sale of health care productsAbbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products.It operates through four reportable segments: Established Pharmaceutical... 
Sector
Pharmaceuticals
Calendar
10/19Earnings Release
More about the company
Advertisement
Financials ($)
Sales 2016 20 943 M
EBIT 2016 3 989 M
Net income 2016 2 323 M
Debt 2016 2 699 M
Yield 2016 2,43%
P/E ratio 2016 23,92
P/E ratio 2017 18,65
EV / Sales 2016 3,14x
EV / Sales 2017 2,99x
Capitalization 62 975 M
More Financials
Chart ABBOTT LABORATORIES
Duration : Period : Day
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Duration : Period : Week
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Surperformance© ratings  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
More Ratings